title: Lack of negative impact of Philadelphia chromosome in older patients with acute lymphoblastic leukaemia in the thyrosine kinase inhibitor era: comparison of two prospective parallel protocols.
authors.forename: Josep-María
authors.initials: JM
authors.lastname: Ribera
authors.forename: Olga
authors.initials: O
authors.lastname: García
authors.forename: Pascual
authors.initials: P
authors.lastname: Fernández-Abellán
authors.forename: Esperanza
authors.initials: E
authors.lastname: Lavilla
authors.forename: María-Teresa
authors.initials: MT
authors.lastname: Bernal
authors.forename: José
authors.initials: J
authors.lastname: González-Campos
authors.forename: Salut
authors.initials: S
authors.lastname: Brunet
authors.forename: María-Carmen
authors.initials: MC
authors.lastname: Monteserín
authors.forename: Pau
authors.initials: P
authors.lastname: Montesinos
authors.forename: Josep
authors.initials: J
authors.lastname: Sarrá
authors.forename: Maria
authors.initials: M
authors.lastname: Calbacho
authors.forename: Alberto
authors.initials: A
authors.lastname: Alvarez-Larrán
authors.forename: Mar
authors.initials: M
authors.lastname: Tormo
authors.forename: Albert
authors.initials: A
authors.lastname: Oriol
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D010677:Philadelphia Chromosome; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics*; D011446:Prospective Studies; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D047428:Protein Kinase Inhibitors; D011505:Protein-Tyrosine Kinases